Cetera Investment Advisers
PPH icon

Cetera Investment Advisers’s VanEck Pharmaceutical ETF PPH Stock Holding History

Cetera Investment Advisers’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.97M Sell
36,292
-1,100
-3% -$114K ﹤0.01% 1782
2026
Q1 		$3.88M Sell
37,392
-2,924
-7% -$311K ﹤0.01% 1692
2025
Q4 		$4.16M Buy
40,316
+4,699
+13% +$457K ﹤0.01% 1597
2025
Q3 		$3.22M Sell
35,617
-400
-1% -$35K ﹤0.01% 1768
2025
Q2 		$3.17M Buy
36,017
+1,387
+4% +$120K 0.01% 1506
2025
Q1 		$3.16M Sell
34,630
-3,166
-8% -$285K 0.01% 1406
2024
Q4 		$3.26M Buy
37,796
+983
+3% +$88.9K 0.01% 1301
2024
Q3 		$3.5M Buy
36,813
+7,365
+25% +$699K 0.01% 1216
2024
Q2 		$2.69M Buy
29,448
+3,237
+12% +$289K 0.01% 1361
2024
Q1 		$2.38M Buy
26,211
+19,912
+316% +$1.74M 0.01% 1429
2023
Q4 		$513K Buy
6,299
+761
+14% +$59.7K ﹤0.01% 1473
2023
Q3 		$442K Buy
5,538
+1,255
+29% +$101K ﹤0.01% 1488
2023
Q2 		$337K Buy
4,283
+109
+3% +$8.53K ﹤0.01% 1667
2023
Q1 		$324K Buy
4,174
+1,253
+43% +$96.6K ﹤0.01% 1657
2022
Q4 		$227K Buy
+2,921
New +$215K ﹤0.01% 1831
2022
Q3 		– Sell
-3,014
Closed -$232K – 1846
2022
Q2 		$232K Buy
3,014
+206
+7% +$16.1K ﹤0.01% 1584
2022
Q1 		$224K Buy
2,808
+150
+6% +$11.5K ﹤0.01% 1646
2021
Q4 		$205K Buy
+2,658
New +$198K ﹤0.01% 1725

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return

Cetera Investment Advisers's PPH Position: Q2 2026 in Review

Cetera Investment Advisers reduced its VanEck Pharmaceutical ETF (PPH) stake by 2.9% in Q2 2026, selling an estimated $114K and leaving 36,292 shares worth $3.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1782.

Cetera Investment Advisers first reported a position in PPH in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.16M in Q4 2025. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Cetera Investment Advisers held 36,292 shares of VanEck Pharmaceutical ETF worth $3.97M as of Q2 2026.
  • Cetera Investment Advisers sold 1,100 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $114K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1782 holding.
  • Cetera Investment Advisers first reported a position in VanEck Pharmaceutical ETF in Q4 2021 and has held it in 18 quarters since.
  • Cetera Investment Advisers's VanEck Pharmaceutical ETF position peaked at $4.16M in Q4 2025.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.